Home / Business and Economy / New CEO Tapped for Diagnostics Firm
New CEO Tapped for Diagnostics Firm
14 Jan
Summary
- David Morris appointed CEO of Proteomics International Laboratories.
- Morris brings extensive healthcare and medtech executive experience.
- Focus on commercial rollout of Promarker diagnostics suite.
Proteomics International Laboratories has welcomed David Morris as its new Chief Executive Officer and Managing Director. Morris brings a wealth of experience from previous leadership roles at prominent healthcare and medtech companies, including Cochlear and Nanosonics.
His mandate is to spearhead the commercial rollout of the company's innovative Promarker diagnostics suite. Morris's proven track record in driving commercial growth and international expansion is seen as critical for accelerating the Promarker precision diagnostics pipeline.
The appointment occurs shortly after the company's US Reference Laboratory in Irvine, California, achieved accreditation from the College of American Pathologists, marking a significant milestone for the firm's operations.
